This year's highly prestigious Champalimaud Vision Award is shared between two worthy winners for their ground-breaking research in neuroscience and how the brain contructs images.
This year's highly prestigious Champalimaud Vision Award is shared between two worthy winners for their ground-breaking research in neuroscience and how the brain contructs images.
The $1.3 million award, the largest of its kind in ophthalmology will be shared between J Anthony Movshon, director of New York University’s Centre for Neural Science and William T. Newsome, a neuroscientist at Stanford University.
For over three decades both scientists have worked jointly and separately on the way our brains process visual information, supporting our perception. Leonor Beleza, president of The Champalimaud Foundation, said: Visual perception starts with the eyes, but it happens in the brain. Over a 30-year period, the work of Movshon and Newsome has taken this axiom to new scientific levels of understanding. Because of these two outstanding neuroscientists, we now have a fundamental appreciation for the role of neurons in how we see things move about in the world. Their ground-breaking work, taken together and individually, has laid the basis for continued research on how the brain and its processes impact vision and perception. We are very proud to recognize Movshon and Newsome as the recipients of the 2010 Champalimaud Vision Award.
According to www.healthnewsdigest.com William Newsome heard about the award following a weekly lab meeting when he listened to his mobile phone messages: There was a message from my wife telling me an ophthalmologist in Portugal had called and told her he was absolutely sure I would really, really want to call him back. The ophthalmologist turned out to be a member of the Champalimaud jury panel: Alfred Summer, MD, dean of the School of Hygiene and Public Health and professor of ophthalmology, epidemiology and international health at Johns Hopkins University.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.